Merck Sharp & Dohme B.V. (primary and secondary packaging, batch release authorization)

The drug is intended for the treatment of adults and children (weighing at least 25 kg) with HIV-1 infection in combination with other antiretroviral agents.

Dosage form: tablets, film-coated

ATC: J05AJ01